7 results found | searching for "Lyon"

• 
• Lyon Vacation Packages From USA Trekhops.com offers exclusive vacation packages to Lyon, ensuring an unforgettable journey. Explore Lyon's rich culture, stunning architecture, and delectable cuisine with expertly planned itineraries. Depart from the USA and immerse yourself in Lyon's charm, indulge in gourmet delights, wander through historic streets, and marvel at UNESCO World Heritage sites. Trekhops handles the details, allowing you to make memories while enjoying the best of Lyon. Book your Lyon vacation package now at trekhops.com https://trekhops.com/tour-packages/lyon

  by trekhopsusa,  Vacation 

  0 reply
• 
• IPL 2023 Final Highlights Match Report TATA IPL 2023 Final Highlights Match Report: Ravindra Jadeja’s heroics propel the Chennai Super Kings to their fifth IPL title. Visit- https://www.icecric.news/csk-vs-gt-ipl-2023-final-highlights-match-report/ #CSKvsGT #CSK #GT #IPL2023 #MatchReport #CSKvsGTHighlights #IPL2023FinalHighlights #cskvsgtmatchreport #ipl2023final #IPL #ChennaiSuperKings #GujaratTitans #bazball #Dhoni #lanBell #Lyon #SportsNews

  by icecricnews,  Sports 

  0 reply
• 
• In a world where an increasing number of people are struggling with weight-related issues, the pursuit of weight loss has become a prevailing goal for many. Beyond the superficial desire for a leaner physique, shedding those extra pounds offers a myriad of remarkable benefits that extend far beyond the number on the scale. From improving overall health and well-being to boosting confidence and self-esteem, weight loss has the power to transform lives in profound ways. Enhanced Physical Health: Weight loss is strongly linked to a range of physical health benefits. Shedding excess body weight can significantly reduce the risk of chronic diseases such as heart disease, type 2 diabetes, certain types of cancer, and hypertension. Moreover, weight loss can alleviate joint pain and improve mobility, making everyday activities easier and more enjoyable. By adopting a healthier lifestyle and losing weight, individuals also experience better sleep patterns, increased energy levels, and a strengthened immune system. https://www.f6s.com/mark-lyon https://dyuccw.contently.com/ https://www.dibiz.com/dyu5cc2w https://promosimple.com/ps/2713b/healthcare https://gleaucs-shrieugy-mcleigh.yolasite.com/ https://dyu5cc2w.hashnode.dev/weight-loss-refers-to-the-process https://wakelet.com/wake/oL0pHi5V-hDToj-PLQK70 https://folkd.com/user/dyu5cc2w https://www.townscript.com/e/weight-loss-324100 https://sway.office.com/RHpi93fFDMuM80lA https://caramel.la/home/oQczY0PSn/Untitled?pub=first http://paradune.com/phorum/read.php?3,236500 https://hackmd.io/63XtBIQNRsWmLDiGMmFgKA https://telescope.ac/ddd/dtfh98k84jzxajfonqoc60 http://www.fxstat.com/en/user/profile/dyu5cc2w-700864/blog/37787586-%E2%80%8BWeight-loss-pills, https://www.rolonet.com/blogs/189683/weight-loss-pills https://www.expatriates.com/cls/53549107.html https://www.adpost4u.com/for-sale/health-beauty/443612/discuss-the-remarkable-benefits-of-weight-loss https://communities.bentley.com/members/fc4c03e2_2d00_2241_2d00_453e_2d00_a778_2d00_aaa1ed80d967 https://influence.co/dyu5cc2w https://my-top-notch-site-95fb15.webflow.io/

  by uuzob0ac,  Health 

  0 reply
• 
• India vs. Australia WTC Final 2023: Who will win the ultimate prize? The World Test Championship (WTC) final in 2023 is set to be a thrilling contest between two of the best teams in the world. India and Australia will face each other at The Oval, London, from June 7 to June 11, to lift the coveted trophy and become the champions of Test cricket. Both teams have had impressive performances in the WTC cycle, winning the series against tough opponents and showing resilience and adaptability in different conditions. India has won seven out of nine series, including a historic triumph in Australia earlier this year. Australia has won six out of eight series, losing only to India and drawing with Sri Lanka. A clash of contrasting strengths and styles will occur in the final. With Rohit Sharma serving as captain, India has one of the best batting lineups in the world across all formats. He will be supported by Virat Kohli, Subhman Gill, Cheteshwar Pujara, and Ajinkya Rahane, who have all shown their class and temperament in Test cricket. India also has a potent bowling attack, with Mohammed Shami, Mohammed Siraj, and Shardul Thakur providing pace and swing, and Ravindra Jadeja and Axar Patel offering spin and control. Australia have a balanced team, with a solid top order comprising Usman Khawaja, David Warner, Marnus Labuschagne, and Steve Smith. Steve Smith is arguably the best Test batsman of his generation and will be eager to prove his mettle in the final. Australia also has a strong lower order, with Cameron Green, Alex Carey, and Mitchell Starc adding depth and firepower. Their bowling unit is one of the best in the world, with Starc, Josh Hazlewood, and Nathan Lyon forming a lethal combination. The pitch at The Oval is expected to be good for batting, with some pace and bounce for the bowlers. The weather forecast is also favourable for cricket, with sunny intervals and mild temperatures throughout the match. Both teams will have to adjust to the English conditions and make the most of their opportunities. The final will be a test of skill, character, and endurance for both teams. It will also be a spectacle for the fans, who will witness some of the finest players in action. India vs. Australia WTC Final 2023: Who will win the ultimate prize? The answer will be revealed soon. For more sports updates and the latest happenings in the world of sports, visit Winmatch. Winmatch is a leading online sports site that offers live scores, online fantasy cricket, live cricket scores, and all sports live updates. For all cricket fans or any other sport, you can find the best odds and betting options on Winmatch. Join today and enjoy the thrill of sports betting. Read More- https://winmatch.com/sportsbook/sport/Cricket

  by chirag_tidal,  Games & Recreation 

  0 reply
• 
• Bacteriophage therapy market Professional Survey Report by 2035 Given the low toxicity, specific targeting and ability to offer higher biosafety, the bacteriophage therapeutics are actively being evaluated for the treatment of various infectious diseases London Roots Analysis has announced the addition of “Bacteriophage Therapeutics Market, 2022-2035” report to its list of offerings. With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases. One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains. With the growing need for therapies targeting AMR infections, bacteriophage therapy is now gaining more traction. Key Market Insights Close to 15 bacteriophage therapeutics are commercialized, while more than 90 are currently at different stages of development Close to 50% of the pipeline candidates are under clinical evaluation; majority (91%) of these candidates are being developed for the treatment of infectious diseases, targeting wide range of bacterial strains. 40+ industry stakeholders claim to have the required capability to manufacture bacteriophage therapeutics The bacteriophage therapy market is currently dominated by the presence of various small players (48%); of these 55% of the players are located in North America, followed by Europe (35%). More than 2,200 articles focused on bacteriophage therapeutics have been published, since 2018 Around 40% of these were published in the last two years, indicating the extensive research activity being carried out in this domain. Close to USD 1,200 million has been invested by both private and public investors, since 2017 Of the total amount invested, over USD 330 million was raised through venture capital funding, representing close to 30% of the overall funding activity in this domain. Further, close to 40% of the instances were, wherein players were collectively awarded more than USD 300 million. Partnership activity within this domain has grown significantly between the time period, 2017-2021 Maximum number of partnerships were established in 2021, indicating a recent rise in the interest of players engaged in this domain. It is worth highlighting that, majority of the deals were related to the research and development (20%), followed by agreements signed for product development (15%). More than 3,500 patients have been enrolled in over 40 clinical trials, worldwide Clinical research activity, in terms of number of trials registered, is reported to has significantly increased in the past few years. Of the total number of trials, close to 35% have already been completed, while 41% are active and still recruiting patients. Europe are anticipated to capture larger share (~95%) of the market by 2035 Currently, in bacteriophage therapeutics market, gastrointestinal infections capture the highest share (~50%) and this trend is unlikely to change in the foreseen future. Further, more than 55% share of the market is captured by oral bacteriophage therapeutics. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market/request-sample.html Key Questions Answered  Which bacteriophage therapeutics candidates are currently under clinical stage of development pipeline?  Who are the leading players engaged in the development of bacteriophage therapeutics?  Which geographies are the most active in conducting clinical trials related to bacteriophage therapeutics?  What is the focus of various publications related to bacteriophage therapeutics?  Which partnership models are commonly adopted by industry and non-industry stakeholders?  What are the investment trends in the industry?  What are the different initiatives undertaken by start-ups for the development of bacteriophage therapeutics in the recent past?  How is the current and future market opportunity likely to be distributed across key market segments? The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:  Type of Therapeutic Area  Gastrointestinal Infections  Bacterial Dysentery  Multiple Infections  Other Infections  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The report features inputs from eminent industry stakeholders, according to whom upcoming generations of bacteriophage therapeutics are likely to garner significant interest among therapy developers and end users alike. The report includes detailed transcripts of discussions held with the following experts:  Antoine Culot (Chief Executive Officer, Rime Bioinformatics)  Mathieu Medina (Project Leader, Hospices Civils De Lyon)  Iddo Weiner (Senior Director, Head of Data-Science, BiomX)  Mohammadreza Azizkhani (Independent Consultant) The research also includes detailed profiles of key players (listed below), featuring an overview of the company, its financial information (if available), detailed information on the advanced stage pipeline candidates and an informed future outlook.  Adaptive Phage Therapeutics  ContaFect  Eliava BioPreparations  Micreos  NPO Microgen  Phagelux  Pherecydes Pharma For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

  by jameshebrew,  Health 

  0 reply
• 
• The bacteriophage therapeutics market is anticipated to grow at a CAGR of 10%, till 2035, claims Roots Analysis Given the low toxicity, specific targeting and ability to offer higher biosafety, the bacteriophage therapeutics are actively being evaluated for the treatment of various infectious diseases London Roots Analysis has announced the addition of “Bacteriophage Therapeutics Market, 2022-2035” report to its list of offerings. With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases. One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains. With the growing need for therapies targeting AMR infections, bacteriophage therapy is now gaining more traction. Key Market Insights Close to 15 bacteriophage therapeutics are commercialized, while more than 90 are currently at different stages of development Close to 50% of the pipeline candidates are under clinical evaluation; majority (91%) of these candidates are being developed for the treatment of infectious diseases, targeting wide range of bacterial strains. 40+ industry stakeholders claim to have the required capability to manufacture bacteriophage therapeutics The bacteriophage therapy market is currently dominated by the presence of various small players (48%); of these 55% of the players are located in North America, followed by Europe (35%). More than 2,200 articles focused on bacteriophage therapeutics have been published, since 2018 Around 40% of these were published in the last two years, indicating the extensive research activity being carried out in this domain. Close to USD 1,200 million has been invested by both private and public investors, since 2017 Of the total amount invested, over USD 330 million was raised through venture capital funding, representing close to 30% of the overall funding activity in this domain. Further, close to 40% of the instances were, wherein players were collectively awarded more than USD 300 million. Partnership activity within this domain has grown significantly between the time period, 2017-2021 Maximum number of partnerships were established in 2021, indicating a recent rise in the interest of players engaged in this domain. It is worth highlighting that, majority of the deals were related to the research and development (20%), followed by agreements signed for product development (15%). More than 3,500 patients have been enrolled in over 40 clinical trials, worldwide Clinical research activity, in terms of number of trials registered, is reported to has significantly increased in the past few years. Of the total number of trials, close to 35% have already been completed, while 41% are active and still recruiting patients. Europe are anticipated to capture larger share (~95%) of the market by 2035 Currently, in bacteriophage therapeutics market, gastrointestinal infections capture the highest share (~50%) and this trend is unlikely to change in the foreseen future. Further, more than 55% share of the market is captured by oral bacteriophage therapeutics. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market/request-sample.html Key Questions Answered  Which bacteriophage therapeutics candidates are currently under clinical stage of development pipeline?  Who are the leading players engaged in the development of bacteriophage therapeutics?  Which geographies are the most active in conducting clinical trials related to bacteriophage therapeutics?  What is the focus of various publications related to bacteriophage therapeutics?  Which partnership models are commonly adopted by industry and non-industry stakeholders?  What are the investment trends in the industry?  What are the different initiatives undertaken by start-ups for the development of bacteriophage therapeutics in the recent past?  How is the current and future market opportunity likely to be distributed across key market segments? The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:  Type of Therapeutic Area  Gastrointestinal Infections  Bacterial Dysentery  Multiple Infections  Other Infections  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The report features inputs from eminent industry stakeholders, according to whom upcoming generations of bacteriophage therapeutics are likely to garner significant interest among therapy developers and end users alike. The report includes detailed transcripts of discussions held with the following experts:  Antoine Culot (Chief Executive Officer, Rime Bioinformatics)  Mathieu Medina (Project Leader, Hospices Civils De Lyon)  Iddo Weiner (Senior Director, Head of Data-Science, BiomX)  Mohammadreza Azizkhani (Independent Consultant) The research also includes detailed profiles of key players (listed below), featuring an overview of the company, its financial information (if available), detailed information on the advanced stage pipeline candidates and an informed future outlook.  Adaptive Phage Therapeutics  ContaFect  Eliava BioPreparations  Micreos  NPO Microgen  Phagelux  Pherecydes Pharma For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: 1. Quantum Computing in Drug Discovery Services Market : - Industry Trends and Global Forecasts, 2023-2035 2. Viral Clearance and Viral Testing Services Market : - Industry Trends and Global Forecasts, 2023-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

  by jameshebrew,  Health 

  0 reply
• 
• Heavy Equipment For Sale Heavy equipment is one of the most important tools that a contractor or homeowner can have in their arsenal. The right platform can make the job much easier, and there are a number of different options to choose from. Some heavy equipment options include bulldozers, backhoes, tractors, and forklifts. Each has its own strengths and weaknesses, so it's important to choose the right one for the task at hand. For example, a bulldozer is great for demolishing large chunks of concrete or asphalt, while a backhoe is perfect for digging trenches and holes. It's also important to consider what type of terrain you'll be working on. For example, if you're a contractor working on a new construction site, you'll likely want an excavator instead of a bulldozer. On the other hand, if you're working on an old property that needs some restoration work done, a tractor might be better suited than an excavator because it's more versatile. No matter which heavy equipment for sale option you choose, be sure to take into account your budget and what type of terrain you're going to be working on. With the right platform in place, you'll be able to sell heavy equipment online with ease. For More Info:-https://www.adlocalpages.com/new-york/syracuse/business-professional-services/alex-lyon-son https://www.lyonauction.com/

  by lyonauction,  Business & Finance 

  0 reply